BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//OncoPlanning//Event//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:b71b9a97-2035-4154-bfe9-52c751fa343b@oncoplanning
DTSTAMP:20260426T212213Z
DTSTART;VALUE=DATE:20270615
DTEND;VALUE=DATE:20270618
SUMMARY:AACR Special Conference in Cancer Research: Cancer Dormancy and Residual Disease
DESCRIPTION:Recent literature underscores that the biology of minimal residual disease (MRD) and tumor dormancy is distinct from that of established metastasis. Key unanswered questions include how DCCs evolve clonally at distant sites\, the epigenetic and transcriptional programs that enforce dormancy\, the role of organ-specific niches and immune surveillance and immune evasion\, and the mechanisms by which dormant cells evade therapy and eventually reactivate. This second AACR conference focused on these topics will bring together basic scientists\, clinicians\, technology developers\, and translational researchers to help catalyze the development of new strategies for tracking\, targeting\, and ultimately eradicating dormant cancer cells – transforming the prospects for true metastasis prevention and long-term cancer survival. Make plans to join us in Toronto for this exciting conference.
LOCATION:Delta Hotel by Marriott\, Toronto\, Ontario\, Canada
URL:https://www.aacr.org/meeting/aacr-special-conference-in-cancer-research-cancer-dormancy-and-residual-disease/
END:VEVENT
END:VCALENDAR